BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15866471)

  • 1. Update on paramyosin in parasitic worms.
    Gobert GN; McManus DP
    Parasitol Int; 2005 Jun; 54(2):101-7. PubMed ID: 15866471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum.
    McManus DP; Liu S; Song G; Xu Y; Wong JM
    Int J Parasitol; 1998 Nov; 28(11):1739-42. PubMed ID: 9846611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis vaccines: Farewell to the God of Plague?
    Taylor MG
    J Trop Med Hyg; 1994 Oct; 97(5):257-68. PubMed ID: 7932921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum.
    Ramirez BL; Kurtis JD; Wiest PM; Arias P; Aligui F; Acosta L; Peters P; Olds GR
    Parasite Immunol; 1996 Jan; 18(1):49-52. PubMed ID: 9223156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview: from the horse experimentation by Prof. Akira Fujinami to paramyosin.
    Kojima S
    Parasitol Int; 2004 Jun; 53(2):151-62. PubMed ID: 15081947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
    Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
    Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of paramyosin as a binding protein for calgranulin C in experimental helminthic keratitis.
    Akpek EK; Liu SH; Thompson R; Gottsch JD
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2677-84. PubMed ID: 12147602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
    Don TA; Bethony JM; Loukas A
    Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma japonicum: immunolocalization of paramyosin during development.
    Gobert GN; Stenzel DJ; Jones MK; Allen DE; McManus DP
    Parasitology; 1997 Jan; 114 ( Pt 1)():45-52. PubMed ID: 9011073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds.
    Li BW; Chandrashekar R; Weil GJ
    J Immunol; 1993 Mar; 150(5):1881-5. PubMed ID: 8436822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of Schistosoma japonicum tegument protein tetraspanin-2: sequence variation and possible implications for immune evasion.
    Cai P; Bu L; Wang J; Wang Z; Zhong X; Wang H
    Biochem Biophys Res Commun; 2008 Jul; 372(1):197-202. PubMed ID: 18486598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.
    Wu HW; Fu ZQ; Lu K; Pond-Tor S; Meng R; Hong Y; Chu K; Li H; Jiz M; Liu JM; Hou M; Park S; Lin JJ; Kurtis JD
    Vaccine; 2017 Jun; 35(26):3409-3415. PubMed ID: 28504194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to schistosomes. Evaluation of mechanisms operating against lung-stage parasites which might be exploited in a vaccine.
    Pemberton RM; Malaquias LC; Falcao PL; Silveira AM; Rabello AL; Katz N; Amorim M; Mountford AP; Coffman RL; Correa-Oliveira R
    Trop Geogr Med; 1994; 46(4 Spec No):247-54. PubMed ID: 7825229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and immunological characterization of the 14-3-3xi molecule from Schistosoma bovis.
    Uribe N; Muro A; Vieira C; Lopez-Aban J; del Olmo E; Suárez L; Martínez-Fernández AR; Siles-Lucas M
    J Parasitol; 2007 Aug; 93(4):964-9. PubMed ID: 17918391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
    Siles-Lucas M; Uribe N; López-Abán J; Vicente B; Orfao A; Nogal-Ruiz JJ; Feliciano AS; Muro A
    Vaccine; 2007 Oct; 25(41):7217-23. PubMed ID: 17707955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization of schistosome proteins.
    Gobert GN
    Microsc Res Tech; 1998 Aug; 42(3):176-85. PubMed ID: 9764918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosome membrane proteins as vaccines.
    Loukas A; Tran M; Pearson MS
    Int J Parasitol; 2007 Mar; 37(3-4):257-63. PubMed ID: 17222846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.